Skin Cancer & Oncology
Expert information on melanoma, basal cell carcinoma, squamous cell carcinoma, precancerous conditions, detection, staging, and treatment options.
ABCDE Rule for Melanoma Detection
ABCDE Rule for Melanoma Detection: clinical evaluation, differential diagnosis, and evidence-based treatment protocols f...
ABCDE Rule for Melanoma: Clinical Application and Detection Sensitivity
Clinical guide to lentigo maligna melanoma: presentation, differential diagnosis, and current treatment standards....
ABCDE Rule for Melanoma: Clinical Application and Detection Sensitivity (Detection Screening)
What dermatologists need to know about abcde rule for melanoma: 90% of primary cutaneous melanomas exhibit at least one ...
Acral Lentiginous Melanoma: Melanoma on Hands and Feet
Treating acral lentiginous melanoma: 10% of melanomas in Caucasian populations but represents 40%. Outcome data and clin...
Actinic Cheilitis: Precancerous Lip Condition
Actinic Cheilitis — 10% of untreated lesions progressing to invasive carcinoma w. 5%, 10% Protocols and clinical pearls ...
Actinic Keratosis: Malignant Potential, Field Cancerization, and Treatment Strategies
Actinic Keratosis: 10% of individual AK lesions transform to invasive squamous . Current management protocols and therap...
Actinic Keratosis: Precancerous Sun Spots
Managing actinic keratosis: treatment algorithms, dosing considerations, and patient monitoring guidelines....
Amelanotic Melanoma: The Colorless Skin Cancer
Amelanotic Melanoma: diagnosis, staging, and current treatment options — a clinical dermatology reference....
Basal Cell Carcinoma Treatment Options: Surgery to Topicals
Treating basal cell carcinoma treatment options: indications, techniques, expected outcomes, and evidence-based protocol...
Basal Cell Carcinoma Types: Nodular Superficial Morpheaform
Expert clinical review of basal cell carcinoma types: diagnostic approach, management protocols, and outcome data....
Basal Cell Carcinoma: Epidemiology, Clinical Subtypes, and Treatment Algorithms
Basal Cell Carcinoma in practice: evaluation, treatment selection, monitoring, and follow-up for dermatologists....
Bowen's Disease (Cutaneous SCC In Situ): Clinical Features, Diagnosis, and Management
Bowen's Disease (Cutaneous SCC In Situ): 5% of Bowen's disease lesions progress to invasive SCC over . From diagnosis to...
Cutaneous SCC: Surgical and Non-Surgical Management
Expert clinical review of cutaneous scc: diagnostic approach, management protocols, and outcome data....
Cutaneous T-Cell Lymphoma: Mycosis Fungoides
Treating cutaneous t-cell lymphoma: indications, techniques, expected outcomes, and evidence-based protocols....
Dermatofibrosarcoma Protuberans: Slow-Growing Skin Sarcoma
Treating dermatofibrosarcoma protuberans: evidence-based protocols, dosing guidelines, and expected outcomes....
Dermoscopy: Diagnostic Technique, Patterns, and Clinical Accuracy for Melanoma and NMSC
How to evaluate and treat dermoscopy: clinical features, diagnostic criteria, and treatment algorithms....
Dermoscopy: Magnified Skin Examination
Dermoscopy in practice: evaluation, treatment selection, monitoring, and follow-up for dermatologists....
Dysplastic Nevi and Atypical Moles: Risk Factors, Malignant Potential, and Surveillance Guidelines
Clinical approach to dysplastic nevi and atypical moles: presentation patterns, diagnostic workup, and management strate...
Dysplastic Nevi: Atypical Moles and Cancer Risk
Dysplastic Nevi: diagnosis, staging, and current treatment options — a clinical dermatology reference....
Field Cancerization: Widespread Sun Damage Treatment
Treating field cancerization: evidence-based protocols, dosing guidelines, and expected outcomes Protocols and clinical ...
Gorlin Syndrome: Multiple Basal Cell Carcinomas
Gorlin Syndrome: 15% of Gorlin syndrome patients develop hundreds of basal ce. Current management protocols and therapeu...
Immunotherapy for Advanced Skin Cancer: Mechanism, Checkpoint Inhibitors, and Clinical Outcomes
Expert clinical review of immunotherapy for advanced skin cancer: diagnostic approach, management protocols, and outcome...
Immunotherapy for Skin Cancer: Checkpoint Inhibitors
Treating immunotherapy for skin cancer: evidence-based protocols, dosing guidelines, and expected outcomes....
Invasive Squamous Cell Carcinoma: Risk Stratification
Invasive Squamous Cell Carcinoma: clinical evaluation, differential diagnosis, and evidence-based treatment protocols fo...
Kaposi Sarcoma: Vascular Skin Tumor
Diagnosing kaposi sarcoma: clinical presentation, histopathology, and current treatment standards Protocols and clinical...
Keratoacanthoma: Rapidly Growing Skin Tumor
Keratoacanthoma — pathophysiology, diagnostic workup, and stepwise treatment algorithms for clinical practice....
Lentigo Maligna Melanoma: Sun-Damaged Skin Cancer
Lentigo Maligna Melanoma — 15% of all cutaneous melanomas and carries intermediate prog. 5%, 15% Protocols and clinical ...
Locally Advanced BCC: Hedgehog Pathway Inhibitors
Treating locally advanced bcc: 50% of facial area) or those invading bone, cartilage, or br. Outcome data and clinical p...
Melanoma Staging and Prognosis: TNM Classification, Breslow Depth, and Survival Outcomes
How to diagnose and manage melanoma staging and prognosis: 90% of melanomas are Stage I-II (localized disease), while d....
Melanoma Staging and Prognosis: TNM Classification, Breslow Depth, and Survival Outcomes (Melanoma)
Melanoma Staging and Prognosis: 90% of melanomas are Stage I-II (localized disease), while d. Current management protoco...
Melanoma Staging: Understanding TNM Classification
Melanoma Staging: clinical evaluation, differential diagnosis, and evidence-based treatment protocols for dermatologists...
Merkel Cell Carcinoma: Epidemiology, Immunotherapy Response, and Staging
Merkel Cell Carcinoma in practice: evaluation, treatment selection, monitoring, and follow-up for dermatologists....
Merkel Cell Carcinoma: Rare Aggressive Skin Cancer
Merkel Cell Carcinoma: 1% of skin cancers but responsible for 10-15% of skin cancer. Current management protocols and th...
Mole Mapping: Digital Surveillance Technology
Mole Mapping — diagnostic criteria, treatment selection, and monitoring in dermatologic practice Protocols and clinical ...
Mycosis Fungoides and Cutaneous T-Cell Lymphoma: Staging, PTNM System, and Treatment
Expert clinical review of mycosis fungoides and cutaneous t-cell lymphoma: diagnostic approach, management protocols, an...
Nodular Melanoma: The Most Dangerous Type
Nodular Melanoma: diagnosis, staging, and current treatment options — a clinical dermatology reference....
Photodynamic Therapy for Skin Cancer and Precancers
Clinical approach to photodynamic therapy for skin cancer and: differential diagnosis, staging, and treatment selection....
Radiation Therapy for Skin Cancer: Comprehensive Overview
What dermatologists need to know: radiation therapy for skin cancer — presentation, workup, and therapeutic approach....
Radiation Therapy for Skin Cancer: When Is It Used
Clinical approach to radiation therapy for skin cancer: differential diagnosis, staging, and treatment selection....
Recurrent Basal Cell Carcinoma: When Cancer Returns
Recurrent Basal Cell Carcinoma — 10% of patients following initial treatment (surgery, radiat. 10%, 20%...
SCC in Immunosuppressed Patients: Transplant Recipients
Expert review of scc in immunosuppressed patients: evaluation, treatment options, and follow-up recommendations....
Self-Skin Exam Guide: Monthly Monitoring
Expert review of self-skin exam guide: evaluation, treatment options, and follow-up recommendations....
Sentinel Lymph Node Biopsy in Melanoma: Indications, Technique, and Prognostic Significance
Sentinel Lymph Node Biopsy in Melanoma: diagnosis, staging, and current treatment options — a clinical dermatology refer...
Sentinel Lymph Node Biopsy: Melanoma Staging Procedure
Managing sentinel lymph node biopsy: treatment algorithms, dosing considerations, and patient monitoring guidelines....
Skin Biopsy: Types, Techniques, and Specimen Handling for Skin Cancer Diagnosis
Treating skin biopsy: evidence-based protocols, dosing guidelines, and expected outcomes Protocols and clinical pearls f...
Skin Cancer Prevention Strategies: What Every Patient Should Know
Clinical approach to skin cancer prevention strategies: differential diagnosis, staging, and treatment selection....
Skin Cancer Survival Rates and Prognosis: Clinical Considerations
Skin Cancer Survival Rates and Prognosis — pathophysiology, diagnostic workup, and stepwise treatment algorithms for cli...
Skin Self-Examination Guide: Surveillance Technique, ABCDE Criteria, and Melanoma Detection
How to diagnose and manage skin self-examination guide: 50% of eligible patients at high risk perform skin self-exam. De...
Squamous Cell Carcinoma in Situ: Bowen Disease
Squamous Cell Carcinoma in Situ: 5% of cutaneous malignancies. Current management protocols and therapeutic consideratio...
Squamous Cell Carcinoma of Skin: Risk Stratification, Mohs Surgery, and Adjuvant Therapy
Squamous Cell Carcinoma of Skin — 5% of cutaneous SCCs develop regional or distant metastases). 5%, Squamous Cell Carcin...
Superficial Spreading Melanoma: Clinical Features, Staging, and Treatment
How to evaluate and treat superficial spreading melanoma: clinical features, diagnostic criteria, and treatment algorith...
Superficial Spreading Melanoma: Most Common Form
How to diagnose and manage superficial spreading melanoma: 80% of all melanomas, characterized by predominantly horizon....
Sézary Syndrome: Advanced Cutaneous T-Cell Lymphoma, Blood Involvement, and Treatment Options
Treating sézary syndrome: 10% of CTCL cases but accounts for disproportionately high m. Outcome data and clinical pearls...
Targeted Therapy for Melanoma: BRAF and MEK Inhibitors
Targeted Therapy for Melanoma in practice: evaluation, treatment selection, monitoring, and follow-up for dermatologists...
Targeted Therapy for Melanoma: BRAF/MEK Inhibitors, KIT Inhibitors, and Personalized Treatment
Clinical guide to targeted therapy for melanoma: 50% of melanomas). Updated protocols Protocols and clinical pearls for ...
Topical Treatments for Skin Cancer: 5-FU and Imiquimod
Topical Treatments for Skin Cancer in practice: evaluation, treatment selection, monitoring, and follow-up for dermatolo...
Total Body Skin Exam: What to Expect
Total Body Skin Exam: 10% of melanoma patients); (3) multiple atypical nevi (5% pr. Current management protocols and the...
UV Damage and Skin Cancer Risk: Evidence-Based Clinical Management
UV Damage and Skin Cancer Risk — diagnostic criteria, treatment selection, and monitoring in dermatologic practice....